Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Topiramate Milpharm 25 mg film-coated tablets {equilateral_black_triangle}

Active Ingredient:
topiramate
Company:  
Aurobindo Pharma - Milpharm Ltd. See contact details
ATC code: 
N03AX11
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Topiramate - Patient Card

{healthcare_pro_orange} For Healthcare Professionals
Topiramate - Pregnancy Prevention Programme: Important information for all female patients who could become pregnant
{pdf_link}

Topiramate - Patient Warning Sticker (Printer friendly)

{healthcare_pro_orange} For Healthcare Professionals
Sticker for Pharmacies - Warning for women who are able to become pregnant.
{pdf_link}

Topiramate Annual Risk Awareness Form - Epilepsy

{healthcare_pro_orange} For Healthcare Professionals
Topiramate - Pregnancy Prevention Programme: Annual Risk Awareness Form Topiramate should not be used in patients of childbearing potential unless the conditions of the Pregnancy Prevention Programme are fulfilled. This form outlines the condition of the Topiramate Pregnancy Prevention Programme and when these must be fulfilled. This form should be used to support and record the prescribing decision.
{pdf_link}

Topiramate Annual Risk Awareness Form - Prophylaxis of Migraine

{healthcare_pro_orange} For Healthcare Professionals
Topiramate - Pregnancy Prevention Programme: Annual Risk Awareness Form - Prophylaxis of Migraine Topiramate should not be used in patients of childbearing potential unless the conditions of the Pregnancy Prevention Programme are fulfilled. This form outlines the conditions of the topiramate Pregnancy Prevention Programme and when these must be fulfilled. The form should be used to support and record the prescribing decision.
{pdf_link}

Topiramate Healthcare Professional Guide - Epilepsy

{healthcare_pro_orange} For Healthcare Professionals
Topiramate Pregnancy Prevention Programme - Healthcare Professionals Guide: Information on the risks of Topiramate use in girls (of any age) and women of childbearing potential in the treatment of epilepsy.
{pdf_link}

Topiramate Healthcare Professional Guide - Prophylaxis of migraine

{healthcare_pro_orange} For Healthcare Professionals
Topiramate - Pregnancy Prevention Programme: Information on the risks of Topiramate use in women of childbearing potential in the treatment of prophylaxis of migraine
{pdf_link}

Topiramate Patient Guide - Epilepsy

{healthcare_pro_orange} For Healthcare Professionals
Topiramate - Pregnancy Prevention Programme - Patient Guide: What patients who are able to get pregnant need to know about Topiramate
{pdf_link}

Topiramate Patient Guide - Prophylaxis of migraine

{healthcare_pro_orange} For Healthcare Professionals
Topiramate - Pregnancy Prevention Programme: Patient Guide: What patients who are able to get pregnant need to know about Topiramate.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Aurobindo Pharma - Milpharm Ltd.
Company image
Address
Odyssey Business Park, Ares Block, West End Road, South Ruislip, Middlesex, HA4 6QD
WWW
http://www.aurobindo.com
Telephone
+ 44 (0)208 845 8811
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)208 845 8811
Medical Information Fax
+44 (0)208 845 8795